Differential Bio Launches AI-Driven Bioprocess Platform

Differential Bio has emerged from stealth with a €2 million funding round to launch its AI-integrated platform aimed at optimizing bioprocess scale-up. This innovation addresses the high costs and slow pace of biomanufacturing, offering firms a way to enhance efficiency and reduce risks in production. The platform’s capabilities could significantly impact sectors such as food and cosmetics by streamlining processes and improving profitability.

Original excerpt: “Biomanufacturing is constrained by a scaling crisis. By leveraging machine learning on extensive phenotypic and bioprocess data, Differential has the potential to redefine biomanufacturing at scale…”

Source: AgFunderNews